All posts by imreal

Lighthouse Autism Center Expands ABA Therapy Services in Elkhart County


autism therapy in Elkhart, Indiana

Children receive one-on-one therapy at Lighthouse Autism Center

“We have been overwhelmed by the number of families inquiring about therapy services in Elkhart. Clearly the need for autism therapy services is great in this community, and we feel privileged to be able to help meet that need.”

Lighthouse Autism Center, a therapy center for children with autism, has announced it will expand ABA services in Elkhart County. Lighthouse, which currently operates eight ABA therapy centers in northern Indiana and southwestern Michigan, plans to open the center in July. This will be the ninth location for Lighthouse Autism Center, which opened its first center in Mishawaka in 2012.

The newest center will be Lighthouse’s second ABA center in Elkhart, Indiana, and will create an additional 35 jobs in the area. Similar to the current Elkhart location, the building will have the capacity to serve upwards of 20 children, providing much needed ABA therapy services to families in the area.

Gregg Maggioli, co-founder and CEO of Lighthouse Autism Center commented, “In August of 2019, we opened our first Elkhart center. Since then, we have been overwhelmed by the number of families inquiring about therapy services for their children. Clearly the need for autism therapy services is great in this community, and we feel privileged to be able to help meet that need.”

The newest center will continue the same proactive health and safety measures seen at Lighthouse’s other autism therapy centers. These include masks for all employees, extra staff on hand to perform cleaning and sanitation throughout the day, limited building capacity, and symptom and temperature checks for children and employees prior to entering a building.

Lighthouse Autism Center provides intensive, center-based therapy utilizing the principles of Applied Behavior Analysis (ABA). Each child’s therapy program is uniquely tailored to their specific needs. Children work on social skills, living skills, school-readiness skills and more.

Lighthouse Autism Center is now enrolling children at their newest location. To learn more and schedule a tour, call 574-387-4313 or visit http://www.lighthouseautismcenter.com/autism-treatment-center-elkhart-indiana.

About Lighthouse Autism Center

Lighthouse Autism Center is an ABA therapy center operated by parents of a child with autism serving Indiana and Michigan. At Lighthouse, we have made it our mission to help children and families by providing the highest quality autism therapy services. To learn how we can help your family, call 574-387-4313 or visit us at http://www.lighthouseautismcenter.com

Share article on social media or email:

hc1 and Airside Partner to Add CV19 Digital ID Capability to hc1 Workforce Advisor™


hc1 and Airside have come together to deliver a privacy-centric mobile solution that enables individual employees to share their lab testing status with their employer in a secure manner.

“By partnering with Airside we are extending the Workforce Advisor solution with a world-class mobile application that can increase safety via a Digital ID that employees can trust to securely share testing status when entering the workplace.”

Bioinformatics leader hc1 and digital identity innovator Airside have partnered to deliver an integrated mobile CV19 Digital ID to hc1 Workforce Advisor™, a cloud-based solution that enables employers to systematically implement and track guidelines that support the ongoing health and safety of employees returning to the workplace.

COVID-19 presents unique challenges to employers as they grapple with how to safely reopen operations. Some of the best ways to keep employees safe include routine lab testing, physical infrastructure reconfiguration, workplace social distancing, and remaining vigilant for symptoms of, and potential exposure to, COVID-19. Faced with an urgent need to quickly implement and enforce a multitude of safety measures, employers are dealing with a massive amount of confusing, and often conflicting, guidance and an overwhelming amount of information to manage. Adding to these unprecedented return to work management challenges, employers must meet data security, privacy, and compliance requirements.

That is why hc1, an expert at securely transforming real-time lab testing data into personalized healthcare insights, and Airside, whose digital identity products are used by more than 8 million people, have come together to deliver a privacy-centric mobile solution that enables individual employees to share their lab testing status with their employer in a secure manner.

“hc1 Workforce Advisor is the only return to work solution for employers that measures and reports the risk of infection at the workplace and in surrounding communities where employees reside,” said Brad Bostic, hc1 CEO. “By partnering with Airside we are extending the Workforce Advisor solution with a world-class mobile application that can increase safety via a Digital ID that employees can trust to securely share testing status when entering the workplace.”

hc1 Workforce Advisor’s CV19 Command Center enables employers to effectively implement and monitor systematic lab testing and symptom checking guidelines for employees consistent with national and local best practices. Using a secure, HIPAA compliant process, lab test results are organized and trends are displayed in easy-to-use dashboards sorted by employee and workplace location. With the integrated mobile application from Airside, employees gain an easy way to do their part in keeping the workplace safe by confirming lab testing guidelines are followed through a secure digital ID that can be scanned when entering any work location.

“Combining hc1’s award-winning platform with our secure mobile application allows for large scale, streamlined, and, most importantly, safe operations when sensitive information sharing is necessary,” said Hans Miller, Founder and CEO of Airside Mobile. “Privacy is equally critical to employees and employers. We empower employees by making sure they control their personal information with transparent consent protocols on their encrypted device. Employers ensure a duty-of-care knowing that employee information is never stored in a central database, and protect against fraud with our easy-to-integrate tool to manage only the necessary information needed for a variety of workplace experiences.”

For more information about hc1 Workforce Advisor for CV19, its unique Command Center, and the integrated Airside Digital ID application for employers, visit http://www.hc1.com/workforce-advisor.

About hc1

Founded to improve lives with high-value care, hc1 has emerged as the leader in bioinformatics for precision testing and prescribing. The cloud-based hc1 High-Value Care Platform® organizes volumes of live data, including lab results, genomics, and medications, to deliver solutions that ensure that the right patient gets the right test and the right prescription. Today, the hc1 Platform powers solutions that optimize diagnostic testing and prescribing for millions of patients nationally. To learn more about hc1’s proven approach to personalizing care while eliminating waste for thousands of health systems, diagnostic laboratories, and health plans, visit http://www.hc1.com and follow us on Twitter, Facebook, and LinkedIn.

About Airside

Airside builds innovative digital identity products for businesses and consumers alike with privacy-by-design and leading-edge security as its guiding principles. Airside’s first product, Mobile Passport, has been downloaded by more than 8 million people and is counted on by more than 30 U.S. airports and cruise ports to reduce shared touchpoints, long lines, and crowding. Mobile Passport is sponsored by the Airports Council International (ACI-NA), and Airlines for America. Airside is headquartered in Arlington, Virginia. Learn more at: http://www.airsidemobile.com or follow us on Twitter, Facebook, Instagram, and LinkedIn.

Share article on social media or email:



A regulatory and clinical perspective for medical devices, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

During uncertain times, it is necessary to understand current regulations and what it means for your development programme.

Due to COVID-19, regulatory agencies are relaxing guidelines and shifting priorities to address shortages in diagnostics and respiratory devices. The current pandemic led to the one-year delay of the new European Union (EU) Medical Device Regulation (MDR), allowing authorities and manufacturers to continue under current procedures. This delay also provides more time for the European Commission to issue guidance documents. Despite this deadline extension, manufacturers should where possible continue with current plans to certify devices under MDR, as Notified Bodies (NB) are continuing to be designated under MDR.

During uncertain times, it is necessary to understand current regulations and what it means for your development programme.

In this webinar, our regulatory and clinical experts will discuss the new challenges arising from the COVID-19 crisis and how to best navigate the regulatory landscape moving forward.


  • Impact on Notified Bodies (NBs) including the one-year delay of MDR, site audits and associated changes within the EU (UK & Brexit, Switzerland, Turkey)
  • Recap of changes to Quality Systems such as the impacts to third party internal audits and supplier audits
  • Considerations for EU and US clinical studies including: CE marking versus US approval processes, emergency use authorization, flexibility in timing and sterilization concerns

Join Sarah Sorrel, President and CEO, MedPass International, an ICON plc company, David Francis, Director of Strategic Consulting, MedPass International, an ICON plc company and Angela Brown, BS, Director, Regulatory Affairs, ICON plc in a live webinar on Thursday, June 11, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Navigating the “New Normal” During COVID-19: A Regulatory and Clinical Perspective for medical devices.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

ESO Announces ESO Fire RMS, the Next Generation Fire Records Management System (RMS) for Fire Departments of All Sizes


News Image

We are leveraging our years of collective wisdom – in partnership with our customers – to deliver an RMS platform for the fire service industry that delivers a state-of-the-art user interface to meet the needs of today’s fire industry.

ESO, the leading data and software company serving emergency medical services (EMS), fire departments, hospitals, and state EMS/Trauma offices today announced ESO Fire RMS, the next generation fire Records Management System (RMS) that is modern, easy to use and integrates across ESO’s broad product ecosystem. The new ESO Fire RMS platform is built on decades of fire service expertise and works for departments of all sizes to better capture data, report on data and create actionable insights with data – including improving community health and safety, as well as addressing responder and provider well-being.

“We believe ESO Fire RMS is the upgrade to the future many fire departments across the country are looking for,” said Allen Johnson, Chief Product Officer for ESO. “We are leveraging our years of collective wisdom – in partnership with our customers – to deliver an RMS platform for the fire service industry that delivers a state-of-the-art user interface to meet the needs of today’s fire industry. This allows responders and providers to quickly and easily capture data for NFIRS and NEMSIS reporting requirements. Additionally, our platform-based approach provides our customers a holistic view of their communities, their people, and their operations.”

Key Components of ESO Fire RMS Include:

  • ESO Fire Incidents: Captures data on critical fire events and automatically submits NFIRS-compliant reports into state repositories.
  • ESO Fire Properties & Inspections: Easily collects and manages data fire departments need to successfully develop preplans and conduct inspections.
  • ESO Activities: Records critical information about community events and operational tasks to create a daily task list and station log, Community Risk Reduction (CRR) events and Length of Service Award Program (LOSAP) – all from within a single application.
  • ESO Hydrants: Captures information about hydrants in an agency’s jurisdiction – as well as maintenance tasks and in-service status – and automatically displays the most up-to-date hydrant information on preplans.
  • ESO Permits: Collects information about permits that were requested and issued in an agency’s jurisdiction; provides tools to print and email those permits to relevant parties.
  • ESO Scheduling: Provides flexible employee scheduling and tracks personnel working in any unit, station, shift, or assignment; data easily integrates with ESO Fire Incidents and common payroll systems.
  • ESO Asset Management: Delivers robust workflow tools, including granular notifications, assignments and asset tracking, to keep departments in tune with their equipment, gear and other key assets.
  • ESO Checklists: Provides easy-to-use digital checklists to capture current condition of vehicles, equipment, places and people.
  • ESO Personnel Management: Manages training, certifications, credentials, work history, demographics, immunizations, and injuries/exposures.
  • ESO Analytics: Makes collected data accessible with one-click reporting for operational, clinical and core measures. Configurable reporting eliminates the need for database manipulation or additional programming.

To learn more about ESO Fire RMS, visit: https://www.eso.com/fire-rms-demo/

About ESO

ESO is dedicated to improving community health and safety through the power of data. Since its founding in 2004, the company continues to pioneer innovative, user-friendly software to meet the changing needs of today’s EMS agencies, fire departments, hospitals and state EMS offices. ESO currently serves thousands of customers throughout North America with a broad software portfolio, including the industry-leading ESO Electronic Health Record (EHR), the next generation ePCR; ESO Health Data Exchange (HDE), the first-of-its-kind healthcare interoperability platform; ESO Fire RMS, the state-of-the-art fire Records Management Systems platform; patient registry software (including trauma registry); and ESO State Repository. ESO is headquartered in Austin, Texas. For more information, visit  http://www.eso.com.

Share article on social media or email:

Validation Institute Verifies Health Performance Claims Of 7 Vendor Programs through Objective, Third-Party Process


News Image

“ Many times performance promises often seem too good to be true and it’s essential for high-quality, value-based, and cost-conscious vendors to stand out and rise to the top,” said RD Whitney, Chief Strategy Officer for Validation Institute.

Validation Institute (VI), an independent, objective, 3rd party organization focused on changing health care, is pleased to announce seven programs have successfully completed validation in April and May of 2020.

“Validation Institute tests the accuracy of health care performance claims by health care vendors making it easier for health benefits professionals to cut through the clutter. Many times performance promises often seem too good to be true and it’s essential for high-quality, value-based, and cost-conscious vendors to stand out and rise to the top,” said RD Whitney, Chief Strategy Officer for Validation Institute.

The following companies have successfully completed validation of one or more programs:

A complete write up of the programs validated can be found here validationinstitute.com/validated-programs/. Validation Institute has validated more than 45 programs representing several different areas of health care services and products.

About Validation Institute

Validation Institute is an independent, objective, 3rd party organization on a mission to improve the quality and cost of healthcare. Based in Portsmouth, N.H., the organization is made up of a network of health benefits purchasers, health benefits advisors, and healthcare solution providers focused on delivering better health value and stronger outcomes than conventional healthcare. http://www.validationinstitute.com

Share article on social media or email:

QCDx Announces Clinical Study for the Determination of Clinical Utility of the QCDx-br™ Liquid Biopsy System to Optimize Treatment Options for Breast Cancer


News Image

QCDx, a private biotech company that has developed a breakthrough Circulating Tumor Cell (CTC) liquid biopsy from a simple blood draw, today announced the initiation of a Clinical Study of the QCDx br™ Liquid Biopsy System to determine its clinical utility for optimizing treatment options for breast cancer patients, both in early and advanced disease. The study has been approved by the University of Connecticut Institutional Review Board and will be conducted in collaboration with the UConn Health, Neag Comprehensive Cancer Center.

“The benefits of monitoring circulating tumor cells with current technology is limited often to prognostication of outcomes for cancer patients” said Dr. Susan Tannenbaum MD, Chief, Division of Hematology/Oncology of the Carole and Ray Neag Comprehensive Cancer Center at UConn Health and Principal Investigator of the Study. “The ability to isolate and then study and characterize individual cells both in terms of gene profiling and protein expression in both early and late stage cancers allows identification of patients at risk for recurrence and allows for targeted treatments based on analyzing these individual cells. This can occur early in the disease and therefore have more impact on outcomes.”

“We are very excited to initiate the QCDx-br™ study with the Neag Comprehensive Cancer Center at UConn Health with Dr. Tannenbaum as Principal Investigator,” said Dr. Triantafyllos (Fyl) Tafas, Founder and CEO of QCDx. “The QCDx-br™ liquid biopsy was designed to tackle the unmet need for detection of CTCs, in both early and advanced disease. It utilizes the RareScope™ instrument, which scans millions of blood cells with an enrichment-free approach, to detect very rare CTCs and characterize different phenotypes, including ones that may have increased metastatic potential or express markers associated with specific cancer treatments. Target cells may be isolated for downstream, single-cell molecular analysis. QCDx-br™ aims to provide the clinical oncologist with early indication of disease progression and new molecular targets that can be used for real-time, personalized treatment.”

Cells from solid tumors enter the blood stream very early in the tumor development, becoming Circulating Tumor Cells that may eventually cause metastasis. By the time a tumor becomes detectable by diagnostic imaging, it contains several million cells and may have genetic heterogeneity. Final diagnosis of cancer is provided by tissue biopsies, which are invasive, cannot be used repeatedly and are ineffective in metastatic disease and assessing treatment effectiveness. CTC liquid biopsies from a simple blood draw can be repeated frequently to reveal disease progression and heterogeneity. The ultimate CTC diagnostic engine must accurately detect and characterize rare CTC originating from the original tumor and/or from metastatic sites. Additionally, by isolating intact and live CTCs for downstream genomic, transcriptomic, epigenetic and other molecular analyses, it will provide guidance for personalized and timely cancer treatment.

About UConn Health:

UConn Health is Connecticut’s only public academic medical center. Based on a 206-acre campus in Farmington, UConn Health has a three-part mission: research, teaching and patient care. Home to the UConn School of Medicine, School of Dental Medicine and UConn John Dempsey Hospital with nearly 5,000 employees supporting nearly 1,000 students, over 800,000 annual patient visits, and innovative scientific research contributing to the advancement of medicine. For more information, visit health.uconn.edu.

About QCDx:

QCDx develops, manufactures and markets tools and integrated systems to detect and monitor cancer at the single cell level. Our technology provides innovative solutions for analyzing all nucleated cells within a blood sample, in an immobilized, multi-million cell suspension, detects intact and live CTCs and isolates for downstream, single-cell molecular analyses. Our technology and products aim to accelerate cancer research and treatment and ultimately transform healthcare.

For more information, visit http://www.qcd-x.com.

Stay in touch on LinkedIn.

Share article on social media or email:

New Precision Linear Stage Family for Ultra High Vacuum Applications


For High Vacuum (HV) and Ultra High Vacuum (UHV) Applications: New High Precision Linear Stages

For High Vacuum (HV) and Ultra High Vacuum (UHV) Applications: New High Precision Linear Stages

A leader in nanopositioning solutions, PI (Physik Instrumente) LP introduces a new high precision linear translation stage family for High Vacuum (HV) and Ultra High Vacuum (UHV) applications. The L-509 vacuum stage series is offered for 3 different vacuum levels: 10-6 hPa, 10-7 hPa, and 10-9 hPa.

Different Linear Motion Ranges

Linear motion ranges of 26mm, 52mm and 102mm are available. The precision-ground ball screw and high resolution motors allow sub-micrometer resolution with excellent position repeatability up to 0.1 microns.

Different Bake-out Temperature Ranges, Different Motors

The new vacuum linear stage series was designed from the ground up for vacuum compatibility, with each component qualified to work under the specified conditions. Everything, from the base materials, nuts and bolts, encoders, cables, limit switches was selected for optimal performance.

Stage variants with closed-loop servo motors with position feedback encoders can be baked out up to 250°F (~120°C), while for the highest vacuum levels, stepper motors (open loop operation) are used. Here, bake-out temperatures of up to 300°F (~150°C) can be reached.

Specifications, Datasheets, More Information»

More Vacuum Compatible Stages»

Other Vacuum and UHV Positioning Products

PI provides a wide range of vacuum and UHV compatible linear stages and rotary stages for nanopositioning and micropositioning applications, including piezo flexure stages, piezo motor solutions and even multi-axis systems such as 6-DOF hexapod parallel positioners to cover the most demanding vacuum motion applications. Industries served include semiconductors, aerospace, optics and photonics, precision automation, life-sciences, and big science research.

Working with You

PI’s in-house engineered systems and components have enabled customers around the world to increase their productivity and technological advantage for 5 decades. With a large basis of standard precision motion products and proven methodologies, PI is in the position to quickly modify existing designs or provide a fully customized OEM solution to fit the exact requirements of your application from the whole motion range from finger-tip sized nano-positioners to large scale stages with long travel ranges, through a plethora of different drives and guiding systems.

USA / Canada

http://www.pi-usa.us | info@pi-usa.us |(508) 832-3456

About PI

PI is a privately held company that designs and manufactures world-class precision motion and automation systems including air bearings, hexapods and piezo drives at locations in North America, Europe, and Asia. The company was founded 5 decades ago and today employs more than 1300 people worldwide. PI’s customers are leaders in high-tech industries and research institutes in fields such as photonics, life-sciences, semiconductors and aerospace.

> READ Tech Blog

> WATCH PI Videos

> FOLLOW on Twitter

> CONNECT on LinkedIn

Share article on social media or email:



Sikka Software announces new service empowering retail healthcare to rebound from the economic impact of the COVID-19 pandemic


Sikka Software, a market leader in advancing retail healthcare connectivity, applications and insights, today announced the launch of Sikka Insights. This new analytics service encompasses the retail healthcare ecosystem of practices, manufacturers, distributors, financial institutions and service providers.

Sikka Insights empowers informed decisions through data insights on scheduling, production, treatment plans, procedures and other key performance indicators (KPIs). With Sikka Insights, it is easy to draw connections between practice activity, shifting demand and constantly changing market conditions. In this new environment, companies in the business of healthcare need to make mission-critical decisions at an unprecedented pace. Making the right decision, with the right data, results in increased revenue, efficiency and value that they can pass on to their customers.

“Wells Fargo Practice Finance has a key focus on helping independently owned healthcare practices grow and manage their businesses,” said Gavin Shea, SVP and National Director, Healthcare at Wells Fargo. “Partnering with Sikka is enabling the practices we support to gain a better understanding of their key performance indicators, and providing Wells Fargo with the industry and market insight that contributes to practice ownership success for our customers.”

An insightful example of the value and timeliness of this data is available on the SIKKA Covid-19 Rebound website. Various retail healthcare segments are displayed in a variety of heat maps, quantifying the impact that the COVID-19 pandemic has had on U.S. practice production and patient visits, and how practices across the 50 states are starting to rebound.

“We are excited to announce the availability of Sikka Insights. This innovative solution brings unprecedented historical data and analytics capabilities to the retail healthcare industry, across dental, orthodontics, chiropractic, optometry and veterinary practices,” commented Vijay Sikka, Founder and CEO of Sikka Software. “We have up to 15 years of data available and over 34,000 practice installations, which means we are able to deliver the industry’s richest data experience. Our manufacturing, DSO/group practice, consulting, analyst and insurance partners – including McKinsey, Wells Fargo and PatientPop – all stand to benefit from these timely insights to guide complex decisions as they navigate today’s challenging business environment.”

About Sikka Software

Sikka Software is helping to rethink the retail healthcare market using a single API cloud platform with Artificial Intelligence and Predictive Analytics. Focusing on non-physician practices in dentistry, audiology, veterinary, optometry, chiropractic, orthodontic and oral surgery, Sikka Software now has over 34,000 practice installations servicing 120 million patients on its platform. These are businesses where the primary skilled workers are also the owners who need tools to digitize their practices and help them make more real-time, optimized decisions. Sikka Software API and cloud platform connect to over 90% of the retail healthcare market, including practice management systems and financial software. For more information, visit http://www.sikkasoft.com

Media Contact:

Alessandra Nagy

714.310.4439

Alessandra@bospar.com

Share article on social media or email:

The American Pet Products Association Encourages Cat Ownership in Celebration of Adopt-a-Cat Month


Snuggle Kitty by SmartPetLove

According to APPA’s 2019-2020 National Pet Owners Survey, benefits of cat ownership include companionship, fun to watch and relieve stress.

In recognition of Adopt-a-Cat Month (June), officials with the American Pet Products Association (APPA) are encouraging responsible cat ownership as the nation celebrates the joys and benefits cats bring to our lives. This pet observance raises awareness about cat adoptions at the peak of “kitten season,” a term which refers to the influx of kittens that come to shelters in June and July. According to APPA’s 2019-2020 National Pet Owners Survey, benefits of cat ownership include companionship, fun to watch and relieve stress. Below are products manufactured by APPA members that can help adopted cats transition smoothly into their “furrever” homes.

The Snuggle Kitty is an all-natural solution for pet anxiety, especially when transitioning to a new home. It soothes kittens by mimicking maternal intimacy through a “real-feel” pulsing heartbeat and physical warmth. Beyond helping with anxiety, the product has saved many orphaned kittens’ lives by taking the place of a mother with the warmth it provides and helping with bottle feeding young kittens.

Price: $39.99

http://www.smartpetlove.com

Cats will enjoy their meals from Scrumptious from Scratch. This gourmet cat food includes human-grade shredded cuts of chicken, turkey and seafood in gravy. All varieties are high in fiber to aid with constipation, diabetes and gut health.

Price: Starts at $0.99/per can

http://www.scrumptiousfromscratch.com

Most cats use a litterbox and finding a place for it can be tough. New Age Pet has made it easy with the LitterLoo Litter Box Cover, End Table. This piece blends in with home décor and serves as a litterbox holder that prevents waste from leaking on the floor. Plus, the easy flip down door makes for easy cleanup.

Price: Starts at $60.00

http://www.newagepet.com

Bath time for cats isn’t always pleasant but with the Waterless Foaming Organic Cat Shampoo by Pure and Natural Pet it can be. No water required, just pump and massage into your cat’s coat. The formula leaves them clean with no residue. It works best if the cat is brushed after use to remove excess hair.

Price: $12.99

http://www.pureandnaturalpet.com

Cats have a natural instinct to scratch which helps stimulate them physically and mentally. The 24” Deco Scratcher from Ware Pet Products satisfies a cat’s natural instinct to scratch, climb, perch or hide. The wood texture laminate base makes this carpeted scratching post not only sturdy but on trend. Made in the USA, this scratcher will provide hours of playtime for any cat.

Price: $24.99

http://www.warepet.com

For more information, product samples, images or interview opportunities, please contact Liz Freeman at 916-606-8795 or liz@theimpetusagency.com.

The American Pet Products Association (APPA) is the leading trade association serving the interests of the pet products industry since 1958. APPA membership includes more than 1,100 pet product manufacturers, their representatives, importers and livestock suppliers representing both large corporations and growing business enterprises. APPA’s mission is to promote, develop and advance pet ownership and the pet product industry and to provide the services necessary to help its members prosper. APPA is also proud to grow and support the industry through the following initiatives: Pets Add Life (PAL), Tony La Russa’s Animal Rescue Foundation (ARF) Pets and Vets Program, the Human Animal Bond Research Institute (HABRI), the Pet Industry Joint Advisory Council (PIJAC), Bird Enjoyment and Advantage Koalition (BEAK), and the Pet Care Trust. Visit http://www.americanpetproducts.org for more information.

Share article on social media or email:

Acuity Eye Group is Open and Serving All Eye Care Patients


“We are confident it is safe for routine patients and elective surgery patients to come in and have adopted additional safety measures to protect patients, doctors, and staff” said Dr. Tom S. Chang.

Acuity Eye Group is committed to serving the patients in its communities and made the decision to reopen on May 18th to all eye care patients in need. During the last few months, Acuity remained open for urgent and emergent eye care patients ensuring those with chronic conditions and at risk for vision loss received the care they needed. “We are confident it is safe for routine patients and elective surgery patients to come in and have adopted additional safety measures to protect patients, doctors, and staff” said Dr. Tom S. Chang.

Acuity has taken additional measures to ensure all patients and team members are protected while in the clinic, such as masking everyone that is in the clinic (doctor, staff, and patient), temperature checking all patients at check-in, and requiring all patients to complete a COVID-19 questionnaire. During the visits, the physicians are educating patients on how to appropriately practice social distancing, how to correctly fit and wear a mask for greatest protection, and are available to answer questions patients and caregivers have as to how best to care for themselves and others during this time.

At Acuity, the health of their patients is their #1 priority and at the heart of every decision they make. Acuity understands that the COVID-19 pandemic will not have a short-term impact on patients and their care but, rather, will become the new norm under which patients and physicians need to function. Acuity has implemented new measures to protect patients and staff and is using the interactions during this time to educate patients and caregivers, giving them the proper tools and information to protect themselves and others in their communities.

Acuity Eye Group has 47 clinics throughout southern and central California and is home to some of the nation’s top ophthalmologists who specialize not only in general ophthalmology, but also in retina disease, pediatric ophthalmology, cataracts, and glaucoma.

About Acuity Eye Group:

At Acuity Eye Group, they are committed to helping ophthalmologists and optometrists realize their full potential while providing best-in-class patient care to all those in need. They are experts in the business of ophthalmology with years of experience in the industry. Acuity Eye Group has world-class doctors and surgeons on their founding team who are still in practice today including Tom S. Chang, Michael Samuel, and Michael Davis. Established as one of the largest, integrated eye care service groups in the country, Acuity Eye Group prides itself on its mission to improve patients’ quality of life through excellence in eye care and patient experience.

Headquartered in Pasadena, CA, the Company offers access to ophthalmology services from Visalia to San Diego. Patients interested in being seen at one of the many Acuity Eye Group clinics in California can schedule appointments through the 24/7 Call Center at 800.898.2020. Those interested can also request appointments directly on the Acuity Eye Group website at acuityeyegroup.com where they will find additional information on Acuity Eye Group’s doctors, locations, and the diseases they treat.

Share article on social media or email: